|
1
|
Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
|
J Rheumatol
|
2005
|
1.27
|
|
2
|
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
|
Oncogene
|
2002
|
1.21
|
|
3
|
The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
|
Arthritis Res Ther
|
2006
|
1.09
|
|
4
|
A3 adenosine receptor as a target for cancer therapy.
|
Anticancer Drugs
|
2002
|
1.07
|
|
5
|
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer.
|
Mod Pathol
|
2008
|
1.07
|
|
6
|
An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.
|
Oncogene
|
2004
|
1.05
|
|
7
|
Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
|
Anticancer Res
|
2003
|
1.02
|
|
8
|
Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents.
|
Exp Hematol
|
2002
|
0.97
|
|
9
|
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
|
Arthritis Res Ther
|
2006
|
0.95
|
|
10
|
Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
|
Exp Dermatol
|
2012
|
0.83
|
|
11
|
CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.
|
Neoplasia
|
2005
|
0.82
|
|
12
|
Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection.
|
Cancer Cytopathol
|
2010
|
0.80
|